St Luke Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 10.00 K
- Company Age 5 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -53.75%
- Profit Growth -3573.03%
- Ebitda -181.53%
- Net Worth -2431.02%
- Total Assets 6.67%
About St Luke Life Sciences
St Luke Life Sciences Private Limited (SLLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 November 2019 (Five years and three months 11 days old ). Its registered office is in Nerkundram, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 10.00 K , as per Ministry of Corporate Affairs (MCA) records.
Muthurajan Narayanan and Ashok Viswanathan serve as directors at the Company.
Company Details
-
Location
Nerkundram, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U51909TN2019PTC132364
-
Company No.
132364
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Nov 2019
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at St Luke Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Muthurajan Narayanan
|
Additional Director | 18-Mar-2024 | Current |
|
Ashok Viswanathan
|
Additional Director | 18-Mar-2024 | Current |
Financial Performance of St Luke Life Sciences.
St Luke Life Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 53.75% decrease. The company also saw a substantial fall in profitability, with a 3573.03% decrease in profit. The company's net worth observed a substantial decline by a decrease of 2431.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of St Luke Life Sciences?
In 2023, St Luke Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Suzron Health Care Private LimitedMuthurajan Narayanan is a mutual person
-
Black Swan Strategic Solutions Private Limited
Muthurajan Narayanan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at St Luke Life Sciences?
Unlock and access historical data on people associated with St Luke Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of St Luke Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped St Luke Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
